MSMR Pub Date : 2025-06-20

{"title":"Exertional rhabdomyolysis among active component members of the U.S. Armed Forces, 2020-2024.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"Exertional rhabdomyolysis is a pathologic muscle breakdown associated with strenuous physical activity. A largely preventable condition, it persists as an occupational hazard of military training and operations, especially in high heat environments among individuals pushing their endurance limits. A total of 464 cases of exertional rhabdomyolysis were identified in 2024, corresponding to a crude incidence rate of 35.9 cases per 100,000 person-years, and is the lowest case count recorded during the 2020-2024 period of surveillance. The 2024 case numbers demonstrated a 9.6% reduction from the peak rate in 2023, and the proportion of 39.7% hospitalized in 2024 represented a 4.0% decrease from 2023. In 2024, all services, excepting the Navy, showed declines in incidence rates, ranging from 2.0% in the Coast Guard to 29.1% in the Air Force, compared to 2023. Consistent with prior reports, subgroup-specific crude rates in 2024 were highest among men, those less than 20 years old, non-Hispanic Black service members, Marine Corps or Army members, and those in combat-specific or 'other' military occupations. Recruit trainees continued to experience the highest rates of exertional rhabdomyolysis in 2024, with a rate more than 13 times greater than officers and enlisted members. During the 2020-2024 surveillance period, 2024 evinced the lowest incidence rate of exertional rhabdomyolysis, nearly 10% lower than the peak observed in 2023. The Air Force showed the largest reduction, with incidence rates decreasing approximately 30% from the previous year.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"32 6","pages":"11-16"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12266732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144545311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter to the editor. 给编辑的信。

MSMR Pub Date : 2025-06-20

Paul D Rockswold, Jill U Riehl

引用次数: 0

Trends of sepsis hospitalizations among female active component U.S. service members, 2011-2022. 2011-2022年美国现役女性军人脓毒症住院趋势

MSMR Pub Date : 2025-05-01

Alexis A McQuistan, Michael T Fan, Sithembile L Mabila

{"title":"Trends of sepsis hospitalizations among female active component U.S. service members, 2011-2022.","authors":"Alexis A McQuistan, Michael T Fan, Sithembile L Mabila","doi":"","DOIUrl":"","url":null,"abstract":"Studies of sepsis within the U.S. military population have consistently shown that rates of sepsis have increased over time. The observed higher incidence of sepsis in studies among women compared to men of the active component U.S. military population is of concern and warrants further evaluation, as it diverges from incidence typically observed in the U.S. general population. The objectives of this study were to examine cases of sepsis among active component U.S. service women between January 1, 2011 and December 31, 2022, compare them to active component men in the U.S. military, and identify factors associated with sepsis among female active component service members. In this study, female active component service members evinced higher rates (66.5 per 100,000 person-years) compared to males (36.7 per 100,000 person-years), with a rate of sepsis 1.9 times higher after adjusting for demographic and military-related factors. Rates of sepsis were higher among women with a history of co-morbidities. Rates of sepsis hospitalizations among female active component service members have consistently been higher compared to male active component members. Female active component members had 1.9 times higher rates for hospitalization for sepsis compared to active component service men after adjusting for demographic and military-related factors.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"32 5","pages":"4-13"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Contraceptive use trends from the Periodic Health Assessment among female active duty U.S. sailors and marines, 2018-2023. 2018-2023年美国女性现役水手和海军陆战队员定期健康评估中的避孕使用趋势

MSMR Pub Date : 2025-05-01

Brooke K Rodriguez, Katherine R Gonzales, Sarah C Kelsey

引用次数: 0

Association between recurring headache and selected women's health issues among U.S. Navy and Marine Corps women: cross-sectional results of the annual Periodic Health Assessment, 2021. 美国海军和海军陆战队女性中经常性头痛与选定女性健康问题之间的关系：年度定期健康评估的横断面结果，2021。

MSMR Pub Date : 2025-05-01

James K Romine, Amber L Dougherty, Mary J Hessert, Andrew J MacGregor

引用次数: 0

Enhancing military women's health and readiness through targeted research initiatives. 通过有针对性的研究举措，加强女兵的健康和战备状态。

MSMR Pub Date : 2025-05-01

Michelle D Lane, Tracy L Behrsing, Miriam E Redington, Akua N Roach, Dwayne L Taliaferro, Katharine W Nassauer, Gayle Vaday

引用次数: 0

Optimizing female warfighter health and performance in environmental extremes. 优化女性战士在极端环境下的健康和表现。

MSMR Pub Date : 2025-05-01

Gabrielle E W Giersch, Karleigh E Bradbury, Nisha Charkoudian

引用次数: 0

Long-acting reversible contraception and unintended pregnancy among U.S. active duty service members, 2017-2018. 2017-2018年美国现役军人的长效可逆避孕和意外怀孕

MSMR Pub Date : 2025-05-01

Clinton Hall, Monica Burrell, Zeina G Khodr, Celeste J Romano, Gia R Gumbs, Ava Marie S Conlin, Kelly O Elmore

引用次数: 0

Infertility among active component service women, U.S. Armed Forces, 2019-2023. 2019-2023年美国武装部队现役女性不孕症

MSMR Pub Date : 2025-05-01

{"title":"Infertility among active component service women, U.S. Armed Forces, 2019-2023.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"This report presents the incidence and prevalence of diagnosed female infertility among active component U.S. service women. During 2019-2023, 8,154 active component women of childbearing potential were diagnosed with incident infertility, resulting in an overall incidence of 77.5 cases per 10,000 person-years (p-yrs). Incidence rates were highest among women in their 30s, non-Hispanic Black individuals, those in health care and pilot or air crew occupations, Army soldiers, and those who were married. From 2019 through 2023, the incidence rate of diagnosed female infertility decreased from 89.2 per 10,000 p-yrs to 69.5 per 10,000 p-yrs despite a concurrent increase in the rate of fertility testing. During the surveillance period, the average annual prevalence of diagnosed female infertility was 1.6%. Of the service women diagnosed with infertility for the first time during the surveillance period, 2,005 (24.6%) delivered live births within 2 years following their incident infertility diagnoses. The incidence rate of diagnosed infertility among service women decreased by 22.1% during the surveillance period, coincident with an increase of 74.0% in the rate of fertility testing from 2019 through 2023.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"32 5","pages":"19-25"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trends in cervical cancer screening modality in the active component U.S. military, 2013-2023. 2013-2023年美国现役军人宫颈癌筛查方式趋势

MSMR Pub Date : 2025-05-01

Meghan Ginn, Shauna L Stahlman, Michael T Fan, Symone Baker Miller

{"title":"Trends in cervical cancer screening modality in the active component U.S. military, 2013-2023.","authors":"Meghan Ginn, Shauna L Stahlman, Michael T Fan, Symone Baker Miller","doi":"","DOIUrl":"","url":null,"abstract":"Cervical cancer screening recommendations have evolved in the past 20 years. Several recent studies have reported on practice pattern changes in the U.S. in response to these guideline changes, but practice patterns have not yet been evaluated in the Military Health System (MHS). Data for active component service women were queried from the Defense Medical Surveillance System for relevant inpatient and outpatient encounter codes within the MHS between January 1, 2013 and December 31, 2023 to identify instances of cervical cancer screening and classify each by modality: cytology alone, HPV alone, and co-testing. Trends in the use of each were evaluated within age categories: younger than age 21 years, ages 21-29 years, ages 30-64 years. A total of 378,952 screening events were captured from 2013 through 2023. MHS practice patterns demonstrated a response to national guideline changes, including increased co-testing and evidence of increasing primary HPV screening among women aged 30-64 years. Cervical cancer screening in women younger than age 21 years markedly decreased following recommendations against screening in this age group. The overall trends in the MHS are similar to those reported in the U.S. general population. Trends in use of each screening modality-cytology, primary HPV, and co-testing-for active component service women are shifting in response to changing national guidelines. There is emerging evidence of increasing primary HPV screening in women ages 30-64 years, especially after 2021.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"32 5","pages":"14-18"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

MSMR最新文献